{"DataElement":{"publicId":"7136570","version":"1","preferredName":"Cell Immunotherapy Administered Type","preferredDefinition":"The response to a question asking to specify the type of cellular immunotherapy administered to a patient.","longName":"CELL_IMM_ADMIN_TP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7136564","version":"1","preferredName":"Cell Immunotherapy Administered","preferredDefinition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._Therapy designed to induce changes in a patient's immune status in order to treat disease._The act of having given something (e.g., a medication or test).","longName":"7136562v1.0:2233610v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"7136562","version":"1","preferredName":"Cell Immunotherapy","preferredDefinition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.:Therapy designed to induce changes in a patient's immune status in order to treat disease.","longName":"C12508:C15262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunotherapy","conceptCode":"C15262","definition":"Therapy designed to induce changes in a patient's immune status in order to treat disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BD19AF8-8570-3274-E053-F662850A6E81","latestVersionIndicator":"Yes","beginDate":"2020-01-10","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-01-10","modifiedBy":"ONEDATA","dateModified":"2020-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BD19AF8-857E-3274-E053-F662850A6E81","latestVersionIndicator":"Yes","beginDate":"2020-01-10","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-01-10","modifiedBy":"SETRAKIN","dateModified":"2020-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7136565","version":"1","preferredName":"Cellular Immunotherapy Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"7136565v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BD19F0F-12B2-3266-E053-F662850A988D","beginDate":"2020-01-10","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-01-10","modifiedBy":"ONEDATA","dateModified":"2020-01-10","deletedIndicator":"No"},{"value":"NK cell therapy","valueDescription":"Natural Killer (NK) cell therapy","ValueMeaning":{"publicId":"7136566","version":"1","preferredName":"Natural Killer (NK) cell therapy","longName":"7136566","preferredDefinition":"Natural Killer (NK) cell therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BD19F0F-12BC-3266-E053-F662850A988D","latestVersionIndicator":"Yes","beginDate":"2020-01-10","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-01-10","modifiedBy":"ONEDATA","dateModified":"2020-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BD19F0F-12D5-3266-E053-F662850A988D","beginDate":"2020-01-10","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-01-10","modifiedBy":"ONEDATA","dateModified":"2020-01-10","deletedIndicator":"No"},{"value":"TIL therapy","valueDescription":"Tumor Infiltrating lymphocytes (TIL) therapy","ValueMeaning":{"publicId":"7136567","version":"1","preferredName":"Tumor Infiltrating lymphocytes (TIL) therapy","longName":"7136567","preferredDefinition":"Tumor Infiltrating lymphocytes (TIL) therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BD19F0F-12DF-3266-E053-F662850A988D","latestVersionIndicator":"Yes","beginDate":"2020-01-10","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-01-10","modifiedBy":"ONEDATA","dateModified":"2020-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BD19F0F-12F8-3266-E053-F662850A988D","beginDate":"2020-01-10","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-01-10","modifiedBy":"ONEDATA","dateModified":"2020-01-10","deletedIndicator":"No"},{"value":"TCR therapy","valueDescription":"T-cell receptor (TCR) therapy","ValueMeaning":{"publicId":"7136568","version":"1","preferredName":"T-cell receptor (TCR) therapy","longName":"7136568","preferredDefinition":"T-cell receptor (TCR) therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BD19F0F-1302-3266-E053-F662850A988D","latestVersionIndicator":"Yes","beginDate":"2020-01-10","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-01-10","modifiedBy":"ONEDATA","dateModified":"2020-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BD19F0F-131B-3266-E053-F662850A988D","beginDate":"2020-01-10","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-01-10","modifiedBy":"ONEDATA","dateModified":"2020-01-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BD19F0F-129C-3266-E053-F662850A988D","latestVersionIndicator":"Yes","beginDate":"2020-01-10","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-01-10","modifiedBy":"SETRAKIN","dateModified":"2020-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Type of Other cellular immuno","type":"Preferred Question Text","description":"Type of Other cellular immunotherapy:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BD19F0F-134C-3266-E053-F662850A988D","latestVersionIndicator":"Yes","beginDate":"2020-01-10","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-01-10","modifiedBy":"SETRAKIN","dateModified":"2020-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}